Latest Breaking News On - Society for surgery of the alimentary tract - Page 3 : comparemela.com

Celltrion USA Announces Two-Year Data For ZYMFENTRATM(Infliximab-Dyyb) To Be Presented At Digestive Disease Week (DDW) 2024 Conference

Celltrion USA Announces Two-Year Data For ZYMFENTRATM(Infliximab-Dyyb) To Be Presented At Digestive Disease Week (DDW) 2024 Conference
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

JerseyNew jerseyUnited statesWashingtonAmericanSarah amundsenNam leeAmerican society for gastrointestinal endoscopyPublic health service actSociety for surgery of the alimentary tractAmerican gastroenterological associationDigestive disease weekMedical directorCelltrion united statesOral presentationDisease week

Celltrion USA announces two-year data for ZYMFENTRA™(infliximab-dyyb) to be presented at Digestive Disease Week (DDW) 2024 Conference

/PRNewswire/ Celltrion USA today announced it will present the two-year results from the extended LIBERTY studies (LIBERTY-CD and LIBERTY-UC) in adult.

JerseyUnited statesNew jerseyWashingtonAmericanNam leeSarah amundsenAmerican society for gastrointestinal endoscopyPublic health service actSociety for surgery of the alimentary tractAmerican gastroenterological associationDigestive diseaseMedical directorCelltrion united statesOral presentationDigestive disease week

AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease Week®

- AbbVie will present 15 abstracts, including three oral presentations, in Crohn s disease and ulcerative colitis reinforcing AbbVie s commitment to advancing.

United statesOhioWashingtonAmericanAnn gastroenterolGastroenterol hepatolAndrew anisfeldNational institute of diabetesInternational organization for the studyTwitterExchange commissionCrohn colitis foundationYoutubeBoehringer ingelheimEuropean medicines agencyAmerican gastroenterological association

Salix Pharmaceuticals: Salix to Present Late-Breaking Data from Phase 2 Trial of Amiselimod in Active Ulcerative Colitis at Digestive Disease Week 2024

Salix Pharmaceuticals: Salix to Present Late-Breaking Data from Phase 2 Trial of Amiselimod in Active Ulcerative Colitis at Digestive Disease Week 2024
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomNew jerseyUnited statesWashingtonAmericanBritishGaren sarafianYasuhiro maedaKevin wigginsKunio sugaharaAmerican society for gastrointestinal endoscopyLinkedinSalix pharmaceuticalsBausch health companies incResearch developmentSociety for surgery of the alimentary tract

Salix to Present Late-Breaking Data from Phase 2 Trial of Amiselimod ...

Salix to Present Late-Breaking Data from Phase 2 Trial of Amiselimod ...
pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.

United statesNew jerseyUnited kingdomWashingtonBritishAmericanKunio sugaharaGaren sarafian kevinYasuhiro maedaSalix pharmaceuticalsNews networkSociety for surgery of the alimentary tractAmerican gastroenterological associationTwitterAmerican society for gastrointestinal endoscopyPharmacological research